$HGEN $31 Pantginis Price Target Easily Met on November P3 Lenzilumab’s topline data -resulting EUA> $50 - this IS the Mayo Clinic’s COVID entry after all. https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-healthcare-companies-humanigen-hgen-and-inmode-inmd/amp/